-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C9M4RrCa45FzIxNx8y8ZNatuUZUvrERfBonX0ORe6774ZerqI+x27+USwTTK0OzJ YmZ0S7Loo8ygkbywhIRvIw== 0001486097-10-000001.txt : 20100316 0001486097-10-000001.hdr.sgml : 20100316 20100316143902 ACCESSION NUMBER: 0001486097-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100316 DATE AS OF CHANGE: 20100316 EFFECTIVENESS DATE: 20100316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeurAxon(USA), Inc. CENTRAL INDEX KEY: 0001486097 IRS NUMBER: 262101767 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-139663 FILM NUMBER: 10685082 BUSINESS ADDRESS: STREET 1: 480 UNIVERSITY AVENUE STREET 2: SUITE 900 CITY: TORONTO STATE: A6 ZIP: M5G 1V2 BUSINESS PHONE: 416-673-6697 MAIL ADDRESS: STREET 1: 480 UNIVERSITY AVENUE STREET 2: SUITE 900 CITY: TORONTO STATE: A6 ZIP: M5G 1V2 D 1 primary_doc.xml X0603 D LIVE 0001486097 NeurAxon(USA), Inc. 480 UNIVERSITY AVENUE SUITE 900 TORONTO A6 M5G 1V2 416-673-6697 DELAWARE None None Corporation true Lawrence E. Bloch 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Director John S. Andrews 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Robert A. Medve 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Suman Rakhit 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Tom Lategan 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Shawn Maddaford 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Executive Officer Andrew Sandham 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Aaron Davidson 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Kenneth Galbraith 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Jonathan R. Goodman 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Deepa Pakianathan 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Samuel P. Wertheimer 480 University Avenue Suite 900 Toronto A6 M5G 1V2 Director Biotechnology Decline to Disclose 06 false 2009-12-21 false true false 0 3568217 3568217 0 false 8 0 0 0 false NeurAxon(USA), Inc. /s/ Lawrence E. Bloch, M.D., J Lawrence E. Bloch, M.D., J.D. Chief Executive Officer 2010-03-05 -----END PRIVACY-ENHANCED MESSAGE-----